Clinical data | |
---|---|
Pronunciation | /ˌmaɪkoʊfɪˈnɒlɪk/ |
Trade names | CellCept, Myfortic, others |
Other names | Mycophenolate sodium, mycophenolate mofetil |
AHFS/ Drugs.com | Monograph |
MedlinePlus | a601081 |
License data | |
Pregnancy category |
|
Routes of administration | By mouth, intravenous [2] |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Bioavailability | 72% (sodium), 94% (mofetil) [3] |
Protein binding | 82–97% [3] |
Metabolism | Liver [3] |
Elimination half-life | 17.9±6.5 hours [3] |
Excretion | Urine (93%), faeces (6%) [3] |
Identifiers | |
| |
Chemical and physical data | |
Formula | C17H20O6 |
Molar mass | 320.341 g·mol−1 |
3D model ( JSmol) | |
| |
| |
(what is this?) (verify) |
Mycophenolic acid (MPA), and also called mycophenolate, is an immunosuppressant medication used to prevent rejection following organ transplantation and to treat Crohn's disease, SLE, interstitial lung disease, and scleroderma. [6] [4] Specifically it is used following kidney, heart, and liver transplantation. [4] It can be given by mouth or by injection into a vein. [4] It comes as mycophenolate sodium and mycophenolate mofetil (MMF). [4]
Common side effects include nausea, infections, and diarrhea. [4] Other serious side effects include an increased risk of cancer, progressive multifocal leukoencephalopathy, anemia, and gastrointestinal bleeding. [4] Use during pregnancy may harm the baby. [4] Effects when taken by the father is unclear. [7] Mycophenolic acid is in the disease-modifying antirheumatic drugs (DMARDs) family of medications. [6] It works by blocking inosine monophosphate dehydrogenase (IMPDH), which is needed by lymphocytes to make guanosine. [4]
Mycophenolic acid was initially discovered by Italian Bartolomeo Gosio in 1893. [8] [9] It was rediscovered in 1945 and 1968. [9] It was approved for medical use in the United States in 1995 following the discovery of its immunosuppressive properties in the 1990s. [4] [8] It is available as a generic medication. [7] In the United Kingdom MMF at a dose of 1.5 gram twice daily costs the NHS about £25 per month as of 2021. [7] In the United States this amount is about US$114. [10] In 2017, it was the 254th most commonly prescribed medication in the United States, with more than one million prescriptions. [11] [12]
{{
cite book}}
: CS1 maint: date format (
link)